Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 113

Results For "CEO"

1714 News Found

Aurobindo Pharma signs MoU with Hare Krishna Charitable Foundation
Sustainability | April 22, 2022

Aurobindo Pharma signs MoU with Hare Krishna Charitable Foundation

A centralised kitchen which provides 5,000 breakfast meals per day is to be started at Perumallapuram, Kakinada, Andhra Pradesh


KBI Biopharma opens mammalian manufacturing facility in North Carolina
News | April 22, 2022

KBI Biopharma opens mammalian manufacturing facility in North Carolina

Company has invested $150 million to build a 150,000 square-foot commercial manufacturing facility in Research Triangle Park (RTP), North Carolina


Agilent joins the National Institute for Innovation in Manufacturing to advance biomanufacturing
News | April 21, 2022

Agilent joins the National Institute for Innovation in Manufacturing to advance biomanufacturing

Support for biologics manufacturability and Industry 4.0 initiatives


Veeva Vault CTMS launched at Bristol Myers Squibb
Medical Device | April 21, 2022

Veeva Vault CTMS launched at Bristol Myers Squibb

Bringing together Bristol Myers Squibb and Celgene on one clinical trial management system, company goes live with Vault CTMS in record speed


ZEISS announces USFDA clearance of the Quatera 700
Digitisation | April 21, 2022

ZEISS announces USFDA clearance of the Quatera 700

The latest technology from ZEISS empowers surgeons with one complete, digitally integrated cataract workflow for efficiency without compromise


India Health Link join hands with U GRO Capital
Healthcare | April 20, 2022

India Health Link join hands with U GRO Capital

U GRO Capital is a listed MSME lending fintech platform


Leading inhalation APIs expert Inke to triple production capacity
Biotech | April 20, 2022

Leading inhalation APIs expert Inke to triple production capacity

To meet the growing global demand for respiratory active pharmaceutical ingredients (APIs), Inke is to invest €9 million into its production plant to reinforce focus on inhalation micronised APIs


SNIPR BIOME initiates first-in-human clinical trial with SNIPR001
Biotech | April 20, 2022

SNIPR BIOME initiates first-in-human clinical trial with SNIPR001

The purpose of the study is to investigate safety and tolerability of SNIPR001 in healthy volunteers and to evaluate the effect of SNIPR001 on reducing E. coli colonization in the gut


MicroGEM granted EUA for Covid-19 PCR Saliva test
Biotech | April 20, 2022

MicroGEM granted EUA for Covid-19 PCR Saliva test

The MicroGEM Saliva test is the first point of care PCR saliva test for Covid-19 delivering results in minutes


Bridge Biotherapeutics enters into an exclusive license agreement with Shaperon
Biotech | April 19, 2022

Bridge Biotherapeutics enters into an exclusive license agreement with Shaperon

By strengthening the company's fibrotic disease development pipeline, Bridge will enhance its strategic focus on the development of comprehensive treatment solutions for idiopathic pulmonary fibrosis (IPF)